These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 23086473)
1. Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. Zaheer S; Thangavel R; Wu Y; Khan MM; Kempuraj D; Zaheer A Neurochem Res; 2013 Jan; 38(1):218-25. PubMed ID: 23086473 [TBL] [Abstract][Full Text] [Related]
2. Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease. Thangavel R; Stolmeier D; Yang X; Anantharam P; Zaheer A Neuropathol Appl Neurobiol; 2012 Oct; 38(6):572-81. PubMed ID: 22035352 [TBL] [Abstract][Full Text] [Related]
3. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain. Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607 [TBL] [Abstract][Full Text] [Related]
4. Immune Suppression of Glia Maturation Factor Reverses Behavioral Impairment, Attenuates Amyloid Plaque Pathology and Neuroinflammation in an Alzheimer's Disease Mouse Model. Ahmed ME; Selvakumar GP; Thangavel R; Kempuraj D; Raikwar SP; Zaheer S; Iyer S; Zaheer A J Neuroimmune Pharmacol; 2021 Jun; 16(2):363-375. PubMed ID: 32504312 [TBL] [Abstract][Full Text] [Related]
5. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy. Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB Front Immunol; 2020; 11():997. PubMed ID: 32508844 [TBL] [Abstract][Full Text] [Related]
6. Augmented expression of glia maturation factor in Alzheimer's disease. Zaheer S; Thangavel R; Sahu SK; Zaheer A Neuroscience; 2011 Oct; 194():227-33. PubMed ID: 21835226 [TBL] [Abstract][Full Text] [Related]
7. Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage. Zaheer A; Zaheer S; Thangavel R; Wu Y; Sahu SK; Yang B Brain Res; 2008 May; 1208():192-203. PubMed ID: 18395194 [TBL] [Abstract][Full Text] [Related]
8. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain. Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001 [TBL] [Abstract][Full Text] [Related]
9. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377 [TBL] [Abstract][Full Text] [Related]
10. Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain. Thangavel R; Kempuraj D; Stolmeier D; Anantharam P; Khan M; Zaheer A Neurochem Res; 2013 Sep; 38(9):1777-84. PubMed ID: 23715664 [TBL] [Abstract][Full Text] [Related]
11. A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. Zaheer A; Zaheer S; Sahu SK; Knight S; Khosravi H; Mathur SN; Lim R J Neurochem; 2007 Apr; 101(2):364-76. PubMed ID: 17250654 [TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679 [TBL] [Abstract][Full Text] [Related]
14. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. Jin JJ; Kim HD; Maxwell JA; Li L; Fukuchi K J Neuroinflammation; 2008 May; 5():23. PubMed ID: 18510752 [TBL] [Abstract][Full Text] [Related]
16. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease. St-Amour I; Bosoi CR; Paré I; Ignatius Arokia Doss PM; Rangachari M; Hébert SS; Bazin R; Calon F J Neuroinflammation; 2019 Jan; 16(1):3. PubMed ID: 30611289 [TBL] [Abstract][Full Text] [Related]
17. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease. Ruan L; Kang Z; Pei G; Le Y Curr Alzheimer Res; 2009 Dec; 6(6):531-40. PubMed ID: 19747158 [TBL] [Abstract][Full Text] [Related]
18. Glia Maturation Factor in the Pathogenesis of Alzheimer's disease. Ramaswamy SB; Bhagavan SM; Kaur H; Giler GE; Kempuraj D; Thangavel R; Ahmed ME; Selvakumar GP; Raikwar SP; Zaheer S; Iyer SS; Govindarajan R; Zaheer A Open Access J Neurol Neurosurg; 2019; 12(3):79-82. PubMed ID: 32775957 [TBL] [Abstract][Full Text] [Related]
19. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain. Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156 [TBL] [Abstract][Full Text] [Related]
20. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease. Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]